Commwell Research & Development is a leader in providing state-of-the-art tools for remote patient monitoring, wellness, remote diagnostic, and interventional patient care. Their flagship product, Health eCare, is a third-generation digital health cloud platform designed as a holistic and open platform. It enables caregivers to design and manage care protocols without coding and offers support for a variety of clinical use cases including home hospitalization, remote patient monitoring, chronic disease management, nursing homes/aging at home, rural and remote locations, rescue and emergency transportation, as well as hotels, malls, and health clubs. The platform connects a vast array of vital signs measurement devices. In addition to Health eCare, Commwell offers PHYSIOGLOVE, a patented 12-lead ECG monitoring device for self-use at home, and SENTINEL, a 2-channel wearable continuous 3-in-1 arrhythmia monitor covering Event, Telemetry, and Holter monitoring. Founded in 1996, Commwell Research & Development is a key player in the Health Care industry, catering to the growing demand for remote and home-based healthcare solutions. As of now, there is no public information available about their latest investment or the investors involved.
There is no investment information
No recent news or press coverage available for Commwell Research & Development.